Murphy Capital Management Inc Eli Lilly & CO Transaction History

Murphy Capital Management Inc

$720 Million
Q2 2022

A detailed history of Murphy Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Murphy Capital Management Inc holds 15,432 shares of LLY stock, worth $13.6 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

15,432

Previous 15,922 3.08%

Holding current value

$13.6 Million

Previous $4.56 Million 9.74%

% of portfolio

0.69%

Previous 0.53%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $136,577 - $160,362	-490 Reduced 3.08%	15,432 $5 Million
Q1 2022 Apr 06, 2022	SELL	$234.69 - $291.66 $83,314 - $103,539	-355 Reduced 2.18%	15,922 $4.56 Million
Q4 2021 Jan 10, 2022	SELL	$224.85 - $279.04 $119,620 - $148,449	-532 Reduced 3.16%	16,277 $4.5 Million
Q3 2021 Oct 22, 2021	SELL	$221.6 - $272.71 $23,268 - $28,634	-105 Reduced 0.62%	16,809 $3.88 Million
Q2 2021 Jul 26, 2021	SELL	$180.55 - $233.54 $25,277 - $32,695	-140 Reduced 0.82%	16,914 $3.88 Million

Q1 2021 Apr 21, 2021	BUY	$164.32 - $212.72 $14,295 - $18,506	87 Added 0.51%	17,054 $3.19 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $144,158 - $190,756	-1,105 Reduced 6.11%	16,967 $2.86 Million
Q3 2020 Oct 20, 2020	BUY	$146.22 - $169.13 $89,047 - $103,000	609 Added 3.49%	18,072 $2.68 Million
Q2 2020 Aug 03, 2020	SELL	$136.42 - $164.18 $20,462 - $24,627	-150 Reduced 0.85%	17,463 $2.87 Million
Q1 2020 Apr 28, 2020	SELL	$119.05 - $147.35 $201,194 - $249,021	-1,690 Reduced 8.76%	17,613 $2.44 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $9,302 - $11,521	-87 Reduced 0.45%	19,303 $2.54 Million
Q3 2019 Oct 11, 2019	SELL	$106.79 - $116.16 $26,163 - $28,459	-245 Reduced 1.25%	19,390 $2.17 Million
Q2 2019 Jul 22, 2019	BUY	$110.79 - $129.32 $287,056 - $335,068	2,591 Added 15.2%	19,635 $2.18 Million
Q1 2019 Apr 11, 2019	SELL	$111.31 - $131.02 $86,042 - $101,278	-773 Reduced 4.34%	17,044 $2.21 Million
Q4 2018 Feb 04, 2019	BUY	$105.9 - $118.64 $63,010 - $70,590	595 Added 3.45%	17,817 $2.06 Million
Q3 2018 Oct 10, 2018	SELL	$85.86 - $107.31 $85,430 - $106,773	-995 Reduced 5.46%	17,222 $1.85 Million
Q2 2018 Jul 26, 2018	SELL	$75.7 - $86.88 $42,770 - $49,087	-565 Reduced 3.01%	18,217 $1.55 Million
Q1 2018 Apr 17, 2018	SELL	$74.21 - $87.6 $54,470 - $64,298	-734 Reduced 3.76%	18,782 $1.45 Million
Q4 2017 Jan 29, 2018	SELL	$81.94 - $87.89 $5,735 - $6,152	-70 Reduced 0.36%	19,516 $1.65 Million
Q3 2017 Oct 19, 2017	BUY	$77.07 - $85.54 $1.51 Million - $1.68 Million	19,586	19,586 $1.68 Million

Others Institutions Holding LLY

# of Institutions

3,755

Shares Held

737M

Call Options Held

7.09M

Put Options Held

7.22M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $835B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Murphy Capital Management Inc with notifications on news.

Account

Murphy Capital Management Inc Eli Lilly & CO Transaction History